A cellular protein called PCa-24 has been identified as a unique marker for prostate cancer.The discovery of the protein, which will be published in the Dec. 15 issue of Cancer, could lead to development of a screening test that clearly distinguishes between prostate cancer and benign prostatic hyperplasia (BPH) before doctors perform a biopsy.
